Tirzepatide 75mg

Tirzepatide (75 mg) is a synthetic lipidated peptide composed of 39 amino acids with a C20 fatty diacid moiety, prepared for non-clinical laboratory research. The tirzepatide peptide has a molecular weight of approximately 4.8 kDa and is supplied as a high-purity (≥98%) lyophilized powder in a sealed research-grade vial.

This format supports research workflows that require larger material availability, including:

• Extended study timelines
• Repeated assay preparation
• Multi-phase experimental designs
• Stock preparation for multiple test conditions

Scientific investigations have examined tirzepatide for research involving:

• Metabolic signaling
• Energy balance
• Glucose-related processes
• Endocrine activity in controlled models

• High-purity tirzepatide peptide intended for laboratory research use
• Batch-tested identity and purity to support reproducibility
• Used in experimental models of metabolic and endocrine function
• Suitable for in vitro and preclinical study designs
• Stable formulation under recommended frozen storage conditions
• Allows precise laboratory reconstitution and handling
• For laboratory research use only.

Tirzepatide is being examined in laboratory models for metabolic regulation and nutrient-response signaling, with research attention on glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor systems.

Common research uses include:

• Mapping system-level metabolic responses under controlled exposure
• Studying energy regulation and glucose processing in standardized models
• Generating measurable laboratory endpoints to support hypothesis testing
• Comparing peptide behavior across in vitro and preclinical conditions

These applications are designed to produce research data and do not represent clinical evaluation.

Published research describes study-dependent protocols. Reported experimental use commonly includes:

• In Vitro Assays: Nanomolar to micromolar concentrations
• Preclinical Models: Weight-adjusted dosing protocols aligned with study objectives

Observed effects are documented as laboratory measurements, which may include:

• Changes in metabolic markers
• Shifts in signaling activity
• Model-specific endpoints tied to energy balance or glucose-related processes

All dosing and observed effects are presented only to support research methodology and experimental reproducibility.

In its lyophilized or powdered state, make sure to adhere to the following storage instructions:

• Store at –20 °C or below
• Protect from light and moisture

After reconstituting the peptide, observe the following:

• Prepare using sterile laboratory techniques
• Store at 2–8 °C
• Use within 72 hours unless stability data indicate otherwise
• Avoid repeated freeze–thaw cycles

For safety and documentation, follow standard laboratory safety practices during handling. Laboratories that buy tirzepatide peptide or order tirzepatide peptide should maintain receiving logs, labeling records, and storage documentation consistent with institutional research guidelines

References

https://www.pnas.org/doi/10.1073/pnas.2116506119

https://pmc.ncbi.nlm.nih.gov/articles/PMC9438179/

https://pmc.ncbi.nlm.nih.gov/articles/PMC9149770/

https://pmc.ncbi.nlm.nih.gov/articles/PMC9396640/

Compliance Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use.